glutathione synthesis aging Impaired in Neurodegeneration Glycine is sold across the

Currently, treatments based on copper metabolism in cardiovascular disease can encompass a wide range of options, including copper chelating agents [such as triethylenetetramine (TETA), tetrathiomolybdate (TTM) and disodium ethylene diamine tetraacetic acid (EDTA)], small-molecule inhibitors of copper chaperone proteins (such as DCAL50), copper ion carriers and natural antidote agents (Table II)

Nature Reviews Drug Discovery 11:191-200

This prompted the creation of C75, a more stable alternative that targets multiple FASN sites, despite retaining side effects similar to those of cerulenin

Clinical validity of delayed recall tests as a gateway biomarker for Alzheimers disease in the context of a structured 5-phase development framework